Product information
From Health Canada
Current status:
Dormant
Current status date:
2015-05-25
Original market date: See footnote 1
1984-12-31
Product name:
POTASSIUM ACETATE INJECTION
Description:
SINGLE-DOSE VIAL
DIN:
02139553 Electronic product monograph is not available
Company:
FRESENIUS KABI CANADA LTD
165 Galaxy Blvd, Suite 100
Toronto
Ontario
Canada
M9W 0C8
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
40:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
B05XA17 POTASSIUM ACETATE
Active ingredient group (AIG) number:See footnote5
0107304002
Active ingredient(s) | Strength |
---|---|
POTASSIUM ACETATE | 392 MG / ML |